FDA Inspection 1005223 — ADPEN Laboratories, Inc.
The FDA completed an inspection of ADPEN Laboratories, Inc. on March 21, 2017 in Jacksonville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 21, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jacksonville, FL (United States)